Drug Patent List
Litigation OpportunitiesNew
Newsletter
Weekly Digest

Pharsight

Nicardipine Hydrochloride Patent Expiration

Nicardipine Hydrochloride is Used for lowering acute elevations of blood pressure in human subjects. It was first introduced by Chiesi Usa Inc in its drug Cardene on Dec 21, 1988. Other drugs containing Nicardipine Hydrochloride are Nicardipine Hydrochloride, Nicardipine Hydrochloride In 0.9% Sodium Chloride, Cardene In 4.8% Dextrose In Plastic Container, Cardene In 0.86% Sodium Chloride In Plastic Container, Cardene Sr, Cardene In 0.83% Sodium Chloride In Plastic Container, Cardene In 5.0% Dextrose In Plastic Container. 20 different companies have introduced drugs containing Nicardipine Hydrochloride.


Nicardipine Hydrochloride Patents

Given below is the list of patents protecting Nicardipine Hydrochloride, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Cardene In 0.83% Sodium Chloride In Plastic Container US7612102 Pre-mixed, ready-to-use pharmaceutical compositions Dec 26, 2027 Chiesi
Cardene In 0.83% Sodium Chloride In Plastic Container US9364564 Pre-mixed, ready-to-use pharmaceutical compositions Dec 26, 2027 Chiesi
Cardene In 0.86% Sodium Chloride In Plastic Container US7612102 Pre-mixed, ready-to-use pharmaceutical compositions Dec 26, 2027 Chiesi
Cardene In 0.86% Sodium Chloride In Plastic Container US9364564 Pre-mixed, ready-to-use pharmaceutical compositions Dec 26, 2027 Chiesi
Cardene In 4.8% Dextrose In Plastic Container US7612102 Pre-mixed, ready-to-use pharmaceutical compositions Dec 26, 2027 Chiesi
Cardene In 4.8% Dextrose In Plastic Container US9364564 Pre-mixed, ready-to-use pharmaceutical compositions Dec 26, 2027 Chiesi
Cardene In 5.0% Dextrose In Plastic Container US7612102 Pre-mixed, ready-to-use pharmaceutical compositions Dec 26, 2027 Chiesi
Cardene In 5.0% Dextrose In Plastic Container US9364564 Pre-mixed, ready-to-use pharmaceutical compositions Dec 26, 2027 Chiesi
Cardene In 0.83% Sodium Chloride In Plastic Container US10758616 Pre-mixed, ready-to-use pharmaceutical compositions Apr 18, 2027 Chiesi
Cardene In 0.83% Sodium Chloride In Plastic Container US11547758 Pre-mixed, ready-to-use pharmaceutical compositions Apr 18, 2027 Chiesi
Cardene In 0.83% Sodium Chloride In Plastic Container US7659291 Methods of treatment with pre-mixed, ready-to-use pharmaceutical compositions Apr 18, 2027 Chiesi
Cardene In 0.83% Sodium Chloride In Plastic Container US8455524 Methods of treatment with pre-mixed, ready-to-use pharmaceutical compositions Apr 18, 2027 Chiesi
Cardene In 0.86% Sodium Chloride In Plastic Container US10758616 Pre-mixed, ready-to-use pharmaceutical compositions Apr 18, 2027 Chiesi
Cardene In 0.86% Sodium Chloride In Plastic Container US11547758 Pre-mixed, ready-to-use pharmaceutical compositions Apr 18, 2027 Chiesi
Cardene In 0.86% Sodium Chloride In Plastic Container US7659291 Methods of treatment with pre-mixed, ready-to-use pharmaceutical compositions Apr 18, 2027 Chiesi
Cardene In 0.86% Sodium Chloride In Plastic Container US8455524 Methods of treatment with pre-mixed, ready-to-use pharmaceutical compositions Apr 18, 2027 Chiesi
Cardene In 4.8% Dextrose In Plastic Container US10758616 Pre-mixed, ready-to-use pharmaceutical compositions Apr 18, 2027 Chiesi
Cardene In 4.8% Dextrose In Plastic Container US11547758 Pre-mixed, ready-to-use pharmaceutical compositions Apr 18, 2027 Chiesi
Cardene In 4.8% Dextrose In Plastic Container US7659291 Methods of treatment with pre-mixed, ready-to-use pharmaceutical compositions Apr 18, 2027 Chiesi
Cardene In 4.8% Dextrose In Plastic Container US8455524 Methods of treatment with pre-mixed, ready-to-use pharmaceutical compositions Apr 18, 2027 Chiesi
Cardene In 5.0% Dextrose In Plastic Container US7659291 Methods of treatment with pre-mixed, ready-to-use pharmaceutical compositions Apr 18, 2027 Chiesi
Cardene In 5.0% Dextrose In Plastic Container US8455524 Methods of treatment with pre-mixed, ready-to-use pharmaceutical compositions Apr 18, 2027 Chiesi



Nicardipine Hydrochloride's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List



Nicardipine Hydrochloride Generics

Several generic applications have been filed for Nicardipine Hydrochloride. The first generic version for Nicardipine Hydrochloride was by Norvium Bioscience Llc and was approved on Jul 18, 1996. And the latest generic version is by Cipla Ltd and was approved on Sep 24, 2024.

Given below is the list of companies who have filed for Nicardipine Hydrochloride generic.


1. AM REGENT

American Regent Inc has filed for 1 generic for Nicardipine Hydrochloride. Given below are the details of the strengths of this generic introduced by Am Regent.

Strength Dosage Form Availability Application Pathway TE code Launch Date
25MG/10ML (2.5MG/ML)

(reference standard)

injectable Prescription INJECTION AP Nov 17, 2009


2. ANI PHARMS

Ani Pharmaceuticals Inc has filed for 2 different strengths of generic version for Nicardipine Hydrochloride. Given below are the details of the strengths of this generic introduced by Ani Pharms.

Strength Dosage Form Availability Application Pathway TE code Launch Date
20MG capsule Discontinued ORAL N/A Dec 10, 1996
30MG capsule Discontinued ORAL N/A Dec 10, 1996


3. BIONPHARMA

Bionpharma Inc has filed for 2 different strengths of generic version for Nicardipine Hydrochloride. Given below are the details of the strengths of this generic introduced by Bionpharma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
20MG capsule Prescription ORAL AB May 3, 2023
30MG capsule Prescription ORAL AB May 3, 2023


4. CHENGDU SHUODE

Chengdu Shuode Pharmaceutical Co Ltd has filed for 1 generic for Nicardipine Hydrochloride. Given below are the details of the strengths of this generic introduced by Chengdu Shuode.

Strength Dosage Form Availability Application Pathway TE code Launch Date
25MG/10ML (2.5MG/ML) injectable Prescription INJECTION AP Sep 6, 2024


5. CIPLA

Cipla Ltd has filed for 2 different strengths of generic version for Nicardipine Hydrochloride. All of these versions come by the name NICARDIPINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE. Given below are the details of the strengths of this generic introduced by Cipla.

Strength Dosage Form Availability Application Pathway TE code Launch Date
20MG/200ML (0.1MG/ML) injectable Prescription INTRAVENOUS AP Sep 24, 2024
40MG/200ML (0.2MG/ML) injectable Prescription INTRAVENOUS AP Sep 24, 2024


6. EPIC PHARMA LLC

Epic Pharma Llc has filed for 2 different strengths of generic version for Nicardipine Hydrochloride. Given below are the details of the strengths of this generic introduced by Epic Pharma Llc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
30MG

(reference standard)

capsule Prescription ORAL AB Mar 19, 1998
20MG capsule Prescription ORAL AB Mar 19, 1998


7. EUGIA PHARMA

Eugia Pharma Specialities Ltd has filed for 1 generic for Nicardipine Hydrochloride. Given below are the details of the strengths of this generic introduced by Eugia Pharma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
25MG/10ML (2.5MG/ML) injectable Prescription INJECTION AP Apr 8, 2021


8. GLENMARK PHARMS LTD

Glenmark Pharmaceuticals Ltd has filed for 2 different strengths of generic version for Nicardipine Hydrochloride. Given below are the details of the strengths of this generic introduced by Glenmark Pharms Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
20MG capsule Prescription ORAL AB Dec 16, 2022
30MG capsule Prescription ORAL AB Dec 16, 2022


9. INFORLIFE

Inforlife Sa has filed for 2 different strengths of generic version for Nicardipine Hydrochloride. Out of these 40mg/200ml (0.2mg/ml) version comes by the name NICARDIPINE HYDROCHLORIDE IN 0.83% SODIUM CHLORIDE, 20mg/200ml (0.1mg/ml) version comes by the name NICARDIPINE HYDROCHLORIDE IN 0.86% SODIUM CHLORIDE. Given below are the details of the strengths of this generic introduced by Inforlife.

Strength Dosage Form Availability Application Pathway TE code Launch Date
40MG/200ML (0.2MG/ML) injectable Prescription INTRAVENOUS AP Apr 17, 2024
20MG/200ML (0.1MG/ML) injectable Prescription INTRAVENOUS AP Apr 17, 2024


10. MICRO LABS

Micro Labs Ltd has filed for 1 generic for Nicardipine Hydrochloride. Given below are the details of the strengths of this generic introduced by Micro Labs.

Strength Dosage Form Availability Application Pathway TE code Launch Date
25MG/10ML (2.5MG/ML) injectable Prescription INJECTION AP Jul 7, 2023


11. NAVINTA LLC

Navinta Llc has filed for 1 generic for Nicardipine Hydrochloride. Given below are the details of the strengths of this generic introduced by Navinta Llc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
25MG/10ML (2.5MG/ML) injectable Discontinued INJECTION N/A Nov 17, 2009


12. NORVIUM BIOSCIENCE

Norvium Bioscience Llc has filed for 2 different strengths of generic version for Nicardipine Hydrochloride. Given below are the details of the strengths of this generic introduced by Norvium Bioscience.

Strength Dosage Form Availability Application Pathway TE code Launch Date
20MG capsule Discontinued ORAL N/A Jul 18, 1996
30MG capsule Discontinued ORAL N/A Jul 18, 1996


13. RK PHARMA

Rk Pharma Inc has filed for 1 generic for Nicardipine Hydrochloride. Given below are the details of the strengths of this generic introduced by Rk Pharma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
25MG/10ML (2.5MG/ML) injectable Prescription INJECTION AP Nov 17, 2009


14. SENORES PHARMS

Senores Pharmaceuticals Inc has filed for 2 different strengths of generic version for Nicardipine Hydrochloride. Given below are the details of the strengths of this generic introduced by Senores Pharms.

Strength Dosage Form Availability Application Pathway TE code Launch Date
20MG capsule Prescription ORAL AB Jul 17, 2023
30MG capsule Prescription ORAL AB Jul 17, 2023


15. SKG PHARMA

Skg Pharma Inc has filed for 2 different strengths of generic version for Nicardipine Hydrochloride. Given below are the details of the strengths of this generic introduced by Skg Pharma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
30MG capsule Prescription ORAL AB Apr 10, 2024
20MG capsule Prescription ORAL AB Apr 10, 2024


16. WEST-WARD PHARMS INT

West-ward Pharmaceuticals International Ltd has filed for 1 generic for Nicardipine Hydrochloride. Given below are the details of the strengths of this generic introduced by West-ward Pharms Int.

Strength Dosage Form Availability Application Pathway TE code Launch Date
25MG/10ML (2.5MG/ML) injectable Discontinued INJECTION N/A Dec 28, 2009


17. WOCKHARDT

Wockhardt Ltd has filed for 1 generic for Nicardipine Hydrochloride. Given below are the details of the strengths of this generic introduced by Wockhardt.

Strength Dosage Form Availability Application Pathway TE code Launch Date
25MG/10ML (2.5MG/ML) injectable Prescription INJECTION AP Nov 17, 2009